The expression status of PD-L1 varies among tumours from different patients, clinically classified as negative, low, or high PD-L1, based on the percentage of tumour cell staining: <1%, ≥ 1% and < 50%, or ≥ 50%, respectively [31]. This evidence concerns the gene CD274 and neoplasm.